POLX.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 10:33):

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom...

Stats
Šios dienos apimtis	60 000.00
Vidutinė apimtis	880 186
Rinkos kapitalizacija	8.16M
EPS	£0 ( 2023-09-14 )
Kita pelno data	( £0 ) 2024-05-23
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.750
ATR14	£0.0440 (1.17%)

Polarean Imaging PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Polarean Imaging PLC Finansinės ataskaitos

Annual	2022
Pajamos:	£1.03M
Bruto pelnas:	£348 276 (33.71 %)
EPS:	£-0.0667

FY	2022
Pajamos:	£1.03M
Bruto pelnas:	£348 276 (33.71 %)
EPS:	£-0.0667

FY	2021
Pajamos:	£1.19M
Bruto pelnas:	£508 025 (42.86 %)
EPS:	£-0.0710

FY	2020
Pajamos:	£1.06M
Bruto pelnas:	£710 467 (67.23 %)
EPS:	£-0.0610

Financial Reports:

No articles found.

Polarean Imaging PLC

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.